These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 39299666)

  • 1. Neuropsychiatric Events Related to Montelukast and Pranlukast in Adults With Asthma and Rhinitis: A 10-Year Nationwide Population-Based Study.
    Jo YW; Kwon HS; Min J; Her Y; Kwon JW
    J Allergy Clin Immunol Pract; 2024 Sep; ():. PubMed ID: 39299666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series.
    Park JS; Cho YJ; Yun JY; Lee HJ; Yu J; Yang HJ; Suh DI;
    Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35595323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study.
    Tsai ML; Lin HC; Yen CH; Ku JT; Sung SY; Chang H
    Children (Basel); 2022 Oct; 9(11):. PubMed ID: 36360335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene antagonists reduce epileptic seizures-related hospitalization in older adult populations with allergic rhinitis or asthma: A population-based cohort study using the Shizuoka Kokuho database: The Shizuoka study.
    Imaichi Y; Nakatani E; Fukutomi Y; Kuriyama N; Mori K; Sugawara A
    Epilepsia Open; 2024 Feb; 9(1):200-209. PubMed ID: 37881138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of leukotriene modifying agent treatment in neuropsychiatric events of elderly asthma patients: a nested case control study.
    Kang SO; Min KH; Kim HJ; Kim TH; Kim W; Lee KE
    Asthma Res Pract; 2021 Mar; 7(1):4. PubMed ID: 33731203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Neuropsychiatric Diseases According to the Use of a Leukotriene Receptor Antagonist in Middle-Aged and Older Adults with Asthma: A Nationwide Population-Based Study Using Health Claims Data in Korea.
    Shim JS; Kim MH; Kim MH; Cho YJ; Chun EM
    J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4290-4297. PubMed ID: 34166842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients.
    Tsai MJ; Wu PH; Sheu CC; Hsu YL; Chang WA; Hung JY; Yang CJ; Yang YH; Kuo PL; Huang MS
    Sci Rep; 2016 Apr; 6():23979. PubMed ID: 27052782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk of Neuropsychiatric Adverse Events With Use of Leukotriene Receptor Antagonists in Patients With Asthma: Analysis of Korea's National Health Insurance Sharing Service Database.
    Kim JH; Lee H; Jeong D; Lee JH; Kwon HS; Song WJ; Cho YS; Kim YJ; Shin YW; Kim TB
    J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3690-3699.e7. PubMed ID: 37660732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of pranlukast and montelukast during the first trimester of pregnancy: A prospective, two-centered cohort study in Japan.
    Hatakeyama S; Goto M; Yamamoto A; Ogura J; Watanabe N; Tsutsumi S; Yakuwa N; Yamane R; Nagase S; Takahashi K; Kosaki R; Murashima A; Yamaguchi H
    Congenit Anom (Kyoto); 2022 Jul; 62(4):161-168. PubMed ID: 35538631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oseltamivir and the Risk of Neuropsychiatric Events: A National, Population-based Study.
    Huh K; Kang M; Shin DH; Hong J; Jung J
    Clin Infect Dis; 2020 Dec; 71(9):e409-e414. PubMed ID: 31996920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene Receptor Antagonists and Risk of Neuropsychiatric Entities: A Meta-Analysis of Observational Studies.
    Bai L; Xu Y; Pan T; Zhang Y; Zhou X; Xu J
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):844-854.e9. PubMed ID: 36473625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations of health-related quality of life questionnaire results in asthma and allergic rhinitis: effects of a leukotriene receptor antagonist.
    Ichimaru Y; Kanazawa H; Kamoi H; Kyoh S; Tochino Y; Kodama T; Hirata K
    J Int Med Res; 2008; 36(3):559-66. PubMed ID: 18534139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Burden Associated with Receiving Inhaled Corticosteroids with Leukotriene Receptor Antagonists or Long-Acting Beta Agonists as Combination Therapy in Older Adults.
    Altawalbeh SM; Thorpe CT; Zgibor JC; Kane-Gill S; Kang Y; Thorpe JM
    J Manag Care Spec Pharm; 2018 May; 24(5):478-486. PubMed ID: 29694289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene receptor antagonists for eczema.
    Ferguson L; Futamura M; Vakirlis E; Kojima R; Sasaki H; Roberts A; Mori R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011224. PubMed ID: 30343498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric side reactions of leukotriene receptor antagonist, antihistamine, and inhaled corticosteroid: A real-world analysis of the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS).
    Bian S; Li L; Wang Z; Cui L; Xu Y; Guan K; Zhao B; Wang L; Yin J
    World Allergy Organ J; 2021 Oct; 14(10):100594. PubMed ID: 34659626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children.
    Brodlie M; Gupta A; Rodriguez-Martinez CE; Castro-Rodriguez JA; Ducharme FM; McKean MC
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008202. PubMed ID: 26482324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS; Cates CJ; Ducharme FM
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation.
    Paljarvi T; Forton J; Luciano S; Herttua K; Fazel S
    JAMA Netw Open; 2022 May; 5(5):e2213643. PubMed ID: 35608857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Chauhan BF; Ducharme FM
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003137. PubMed ID: 24459050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.